leadf
logo-loader
OTCQB:BIOAF TSX-V:BTI

Bioasis Technologies Inc.

Receive alerts
Market:
OTCQB
Market Cap:
$16.56 m
Price
0.23 USD
Change
18.53%
52 weeks high
0.55
52 weeks low
0.18

In brief

Bioasis Technologies Inc. is a biopharmaceutical company developing the xB3TM platform, a proprietary technology for the delivery of therapeutics across the BBB and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The delivery of therapeutics across the BBB represents the final frontier in treating neurological disorders. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders. The company maintains headquarters in Guilford, Conn., United States. Bioasis trades on the TSX Venture Exchange under the symbol “BTI” and on the OTCQB under the symbol “BIOAF.”